微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.27% | 74.62% | -58.65% | 39/130 | 1.05% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 5.49% | 149.55% | 13.9% | 57/130 | 3.06% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.82% | 223.49% | 55.48% | 58/130 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.1% | 302.6% | 138.46% | 58/130 | 3.07% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.3% | 208.33% | -40.91% | 66/130 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.2% | 160.61% | 47.65% | 92/130 | 5.09% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 1.49% | 77.38% | 93.51% | 97/130 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.77% | 1200% | 164.17% | 102/130 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | -1.2% | -1100% | 66.94% | 117/130 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | -3.63% | -1678.26% | -532.14% | 117/130 | 13.41% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 0.84% | -78.57% | 1300% | 103/130 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -0.07% | -103.47% | -158.33% | 114/130 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.12% | -92.68% | -47.83% | 100/130 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 0.23% | -97.75% | -94.13% | 119/130 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 3.92% | -56.44% | 94.06% | 95/130 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.02% | -46.13% | 23.17% | 106/130 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.64% | 86.36% | -83.95% | 82/130 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 10.22% | 112.03% | 13.56% | 88/130 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 9% | 94.81% | 140% | 55/130 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 3.75% | 79.43% | 326.14% | 80/130 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.88% | 91.3% | -81.74% | 59/130 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 4.82% | 62.29% | 4.33% | 98/130 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.62% | 36.69% | 121.05% | 53/130 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 2.09% | 344.68% | 354.35% | 59/130 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.46% | -24.59% | -84.51% | 51/130 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 2.97% | 143.44% | -12.13% | 88/130 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 3.38% | 692.98% | 619.15% | 47/130 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 0.47% | 113.2% | -22.95% | 53/130 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 0.61% | -68.23% | -50% | 46/130 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 1.22% | -95.37% | 314.04% | 90/130 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | -0.57% | 2% | 83.99% | 47/130 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | -3.56% | -125.07% | -285.42% | 57/130 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.92% | -64.04% | -92.72% | 27/130 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 26.36% | 34.22% | 85.63% | 17/130 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-06-30 | 14.2% | -8.68% | -27.7% | 6/130 | 6.26% | 安图生物 | 28% | 行业排名> |
| 2015-12-31 | 19.64% | -29.12% | 267.79% | 17/130 | 15.95% | 明德生物 | 23.29% | 行业排名> |
| 2015-03-31 | 5.34% | 2% | -80.73% | 8/130 | 3.2% | 健帆生物 | 7.75% | 行业排名> |